Literature DB >> 20714885

Noninvasive diagnosis of cardiac amyloidosis by MRI and echochardiography.

Jing Wang1, Xiangquan Kong, Haibo Xu, Guofeng Zhou, Dandan Chang, Dingxi Liu, Li Zhang, Mingxing Xie.   

Abstract

This study described the radiological features on echocardiography and MRI specific to cardiac amyloidosis confirmed on biopsy. Eleven cases of biopsy-proven cardiac amyloidosis were retrospectively reviewed in this study. All patients underwent biopsy, cardiac MRI and echocardiography. The main echocardiography and MRI findings were as follows: diffuse ventricular and septum wall thickening, atrial enlargement, pericardial effusion, restricted left ventricular (LV) systolic and diastolic function, characteristic granular sparkling of myocardium. MRI revealed a characteristic pattern of global subendocardial late enhancement, extending in varying degrees into the neighboring myocardium. The findings agreed with the infiltration distribution of amyloid protein. Typical abnormalities seen on echocardiography and MRI should have important diagnostic and prognostic value of cardiac amyloidosis. MRI should be considered in the diagnosis of cardiac amyloidosis if echocardiographic features are suspicious.

Entities:  

Mesh:

Year:  2010        PMID: 20714885     DOI: 10.1007/s11596-010-0464-y

Source DB:  PubMed          Journal:  J Huazhong Univ Sci Technolog Med Sci        ISSN: 1672-0733


  20 in total

Review 1.  Diagnosis and management of the cardiac amyloidoses.

Authors:  Rodney H Falk
Journal:  Circulation       Date:  2005-09-27       Impact factor: 29.690

2.  Doppler index combining systolic and diastolic myocardial performance: clinical value in cardiac amyloidosis.

Authors:  C Tei; K S Dujardin; D O Hodge; R A Kyle; A J Tajik; J B Seward
Journal:  J Am Coll Cardiol       Date:  1996-09       Impact factor: 24.094

3.  Non-invasive evaluation of the myocardial substrate of cardiac amyloidosis by gadolinium cardiac magnetic resonance.

Authors:  E Perugini; C Rapezzi; T Piva; O Leone; L Bacchi-Reggiani; L Riva; F Salvi; L Lovato; A Branzi; R Fattori
Journal:  Heart       Date:  2005-06-06       Impact factor: 5.994

4.  Cardiovascular magnetic resonance in cardiac amyloidosis.

Authors:  Alicia Maria Maceira; Jayshree Joshi; Sanjay Kumar Prasad; James Charles Moon; Enrica Perugini; Idris Harding; Mary Noelle Sheppard; Philip Alexander Poole-Wilson; Philip Nigel Hawkins; Dudley John Pennell
Journal:  Circulation       Date:  2005-01-03       Impact factor: 29.690

Review 5.  Amyloidosis and the heart: a comprehensive review.

Authors:  Keyur B Shah; Yoshio Inoue; Mandeep R Mehra
Journal:  Arch Intern Med       Date:  2006-09-25

6.  Comparison of electrocardiographic findings in patients with AL (primary) amyloidosis and in familial amyloid polyneuropathy and anginal pain and their relation to histopathologic findings.

Authors:  M Hongo; H Yamamoto; T Kohda; M Takeda; O Kinoshita; S Uchikawa; H Imamura; K Kubo
Journal:  Am J Cardiol       Date:  2000-04-01       Impact factor: 2.778

7.  [The clinical features and outcomes of immunoglobulin light-chain amyloidosis with heart involvement].

Authors:  Lei Meng; Wen-Hui Ding; Li-Bin Shi; Yan-Jun Gong; Zhao-Ping Liu
Journal:  Zhonghua Xin Xue Guan Bing Za Zhi       Date:  2007-04

8.  M-mode and two-dimensional echocardiographic features in cardiac amyloidosis.

Authors:  A G Siqueira-Filho; C L Cunha; A J Tajik; J B Seward; T T Schattenberg; E R Giuliani
Journal:  Circulation       Date:  1981-01       Impact factor: 29.690

9.  Cardiovascular magnetic resonance in clinically suspected cardiac amyloidosis: noninvasive imaging compared to endomyocardial biopsy.

Authors:  Holger Vogelsberg; Heiko Mahrholdt; Claudia C Deluigi; Ali Yilmaz; Eva M Kispert; Simon Greulich; Karin Klingel; Reinhard Kandolf; Udo Sechtem
Journal:  J Am Coll Cardiol       Date:  2008-03-11       Impact factor: 24.094

10.  Sensitivity and specificity of the echocardiographic features of cardiac amyloidosis.

Authors:  R H Falk; J F Plehn; T Deering; E C Schick; P Boinay; A Rubinow; M Skinner; A S Cohen
Journal:  Am J Cardiol       Date:  1987-02-15       Impact factor: 2.778

View more
  2 in total

Review 1.  Pathophysiology and treatment of cardiac amyloidosis.

Authors:  Morie A Gertz; Angela Dispenzieri; Taimur Sher
Journal:  Nat Rev Cardiol       Date:  2014-10-14       Impact factor: 32.419

2.  Cardiac magnetic resonance imaging of systemic amyloidosis patients with normal left ventricular ejection fraction: An initial study.

Authors:  Rui Xia; Fabao Gao; Jiayu Sun; Chunchao Xia; Zhangxue Hu; Yingkun Guo
Journal:  Pak J Med Sci       Date:  2013-11       Impact factor: 1.088

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.